Latest Investment News

Australian Foundation Investment Company plans special fully franked dividends alongside its 2026 interim and final payouts, leveraging a strong franking credit balance.

L1 Long Short Fund Limited has updated its dividend notification to include the Dividend Reinvestment Plan price, confirming a fully franked quarterly payout and new issue securities.

Acrux Ltd reported a remarkable surge in licensing revenue from its topical generics portfolio alongside a strategic pivot towards innovative drug delivery R&D at its 2025 Annual General Meeting.

Aroa Biosurgery reported a 14% rise in product sales to NZ$44.6 million for the half-year ended September 2025, driven by strong growth in its Myriad portfolio. The company also posted a normalised EBITDA profit and reaffirmed its FY26 revenue and profit guidance.

Whitefield Income Limited has launched a A$53 million placement at a 5.2% discount to recent prices, aiming to bolster its investment strategy with fresh capital.

Patronus Resources has confirmed a standout uranium intercept of 10.76m at 2.95% U3O8 at its Thunderball deposit, spotlighting a newly identified Upper Lode and bolstering the prospect of a multi-deposit uranium district in the Northern Territory.

Web Travel Group Limited has reported a robust first half of FY26 with a 22% increase in Total Transaction Value and EBITDA growth surpassing expectations, setting a confident tone for the year ahead.

WEB Travel Group has reported a stellar first half of FY26, posting a 22% rise in Total Transaction Value to $3.2 billion alongside strong EBITDA growth, signaling robust momentum ahead of full-year results.

Web Travel Group Limited reports robust half-year results for FY26, with its B2B travel division WebBeds fueling a 20% revenue increase despite rising costs and finance pressures.

Bio-Gene Technology Limited has received a $519,500 R&D tax incentive from the Australian government, supporting its development of innovative bio-insecticides targeting insecticide resistance.

Pacific Edge reports a $19.1 million net loss for the first half of FY26 amid Medicare coverage loss but positions itself for a Medicare-led recovery with strong clinical evidence and a key advisory committee meeting set for February 2026.

Euroz Hartleys Group Limited reported a robust FY2025 with an 87.7% jump in net profit and a strong start to FY2026, driven by increased brokerage and capital markets activity.